SEC Form 4 · accession 0001070081-17-000049
PTC THERAPEUTICS, INC. · PTCT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David P Southwell
Director
Period of report
Jan 3, 2017
Accepted (ET)
Jan 9, 2017 · 5:39 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070081
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right To Buy)F1 | $11.23 | Jan 3, 2017 | A | 12,000 | A | — | Jan 2, 2027 | Common Stock | 12,000 | 12,000 | D |
Explanation of responses
- F1This option was granted on January 3, 2017 and vests over one year in twelve equal monthly installments, commencing on February 3, 2017.